Russell-Jones R - Search Results

1

Predictors of patient satisfaction with initial diagnosis and management of malignant melanoma.

Sheth N, Sarker SJ, Harries M, Healy C, Russell-Jones R, Acland K. Sheth N, et al. Among authors: russell jones r. Clin Exp Dermatol. 2010 Aug;35(6):599-602. doi: 10.1111/j.1365-2230.2009.03639.x. Epub 2009 Oct 23. Clin Exp Dermatol. 2010. PMID: 19874330

2

Cutaneous malignant melanoma in association with mycosis fungoides.

Evans AV, Scarisbrick JJ, Child FJ, Acland KM, Whittaker SJ, Russell-Jones R. Evans AV, et al. J Am Acad Dermatol. 2004 May;50(5):701-5. doi: 10.1016/j.jaad.2003.11.054. J Am Acad Dermatol. 2004. PMID: 15097953

3

The value of positron emission tomography scanning in the detection of subclinical metastatic melanoma.

Acland KM, O'Doherty MJ, Russell-Jones R. Acland KM, et al. J Am Acad Dermatol. 2000 Apr;42(4):606-11. J Am Acad Dermatol. 2000. PMID: 10727305

4

Sentinel node biopsy in the management of malignant melanoma.

Russell-Jones R, Acland K. Russell-Jones R, et al. Clin Exp Dermatol. 2001 Sep;26(6):463-8. doi: 10.1046/j.1365-2230.2001.00868.x. Clin Exp Dermatol. 2001. PMID: 11678867 Review.

5

Serum S100 concentrations are not useful in predicting micrometastatic disease in cutaneous malignant melanoma.

Acland K, Evans AV, Abraha H, Healy CM, Roblin P, Calonje E, Orchard G, Higgins E, Sherwood R, Russell-Jones R. Acland K, et al. Br J Dermatol. 2002 May;146(5):832-5. doi: 10.1046/j.1365-2133.2002.04691.x. Br J Dermatol. 2002. PMID: 12000380

6

Does deprivation of area of residence influence the incidence, tumour site or T stage of cutaneous malignant melanoma? A population-based and clinical database study.

Grunewald T, Davies E, Mak V, Russell-Jones R, Acland K, Møller H. Grunewald T, et al. Clin Exp Dermatol. 2007 Sep;32(5):574-7. doi: 10.1111/j.1365-2230.2007.02456.x. Epub 2007 May 16. Clin Exp Dermatol. 2007. PMID: 17509058

7

Systemic B-cell lymphoma presenting as an isolated lesion on the ear.

Darvay A, Russell-Jones R, Acland KM, Lampert I, Chu AC. Darvay A, et al. Clin Exp Dermatol. 2001 Mar;26(2):166-9. doi: 10.1046/j.1365-2230.2001.00786.x. Clin Exp Dermatol. 2001. PMID: 11298107

8

Comparison of positron emission tomography scanning and sentinel node biopsy in the detection of micrometastases of primary cutaneous malignant melanoma.

Acland KM, Healy C, Calonje E, O'Doherty M, Nunan T, Page C, Higgins E, Russell-Jones R. Acland KM, et al. J Clin Oncol. 2001 May 15;19(10):2674-8. doi: 10.1200/JCO.2001.19.10.2674. J Clin Oncol. 2001. PMID: 11352959

9

High-dose interferon and the U.K. guidelines for cutaneous melanoma.

Russell-Jones R, Healy C, Calonje E, Doherty M, Acland K. Russell-Jones R, et al. Br J Dermatol. 2002 Oct;147(4):832-4; author reply 834-5. doi: 10.1046/j.1365-2133.2002.505517.x. Br J Dermatol. 2002. PMID: 12366454 No abstract available.

10

Striae formation in two HIV-positive persons receiving protease inhibitors.

Darvay A, Acland K, Lynn W, Russell-Jones R. Darvay A, et al. J Am Acad Dermatol. 1999 Sep;41(3 Pt 1):467-9. doi: 10.1016/s0190-9622(99)70122-2. J Am Acad Dermatol. 1999. PMID: 10459124 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

165 results

Search Page

Filters